Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 121 citing articles:

Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET)
Meredith Giuliani, Édith Filion, Sergio Faria, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 120, Iss. 3, pp. 669-677
Open Access | Times Cited: 29
Radiotherapy and immunology
Liangliang Wang, Connor Lynch, Sean P. Pitroda, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 7
Open Access | Times Cited: 26
Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113–08113 LungTech Phase II Trial Results
Antonin Lévy, Sonja Adebahr, Coen Hurkmans, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 9, pp. 1297-1309
Closed Access | Times Cited: 19
Radiotherapy, immunity, and immune checkpoint inhibitors
Connor Lynch, Sean P. Pitroda, Ralph R. Weichselbaum
The Lancet Oncology (2024) Vol. 25, Iss. 8, pp. e352-e362
Closed Access | Times Cited: 19
New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe
Ilias Houda, Chris Dickhoff, Carin A. Uyl‐de Groot, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100840-100840
Open Access | Times Cited: 15
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives
Amy J. Wisdom, Christopher A. Barker, Joe Y. Chang, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1404-1421
Closed Access | Times Cited: 13
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
Liang Zhao, Yizhen Pang, Yangfan Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
Fei Zhou, Haoyue Guo, Yang Xia, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 10
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
Yvonne M. Mowery, Karla V. Ballman, Angela Hong, et al.
The Lancet (2024) Vol. 404, Iss. 10467, pp. 2053-2064
Closed Access | Times Cited: 9
Immunotherapy and Radiation Therapy Sequencing in Breast Cancer: A Systematic Review
Saurav Verma, Sympascho Young, Gabriel Boldt, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1422-1434
Open Access | Times Cited: 8
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 8
Real-world acute toxicity and 90-day mortality in patients with stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
Peter S.N. van Rossum, Nienke Wolfhagen, Liselotte W. van Bockel, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 11, pp. 1550-1563
Closed Access | Times Cited: 8
Hydrogen‐Bonded Organic Framework Nanoscintillators for X‐Ray‐Induced Photodynamic Therapy in Hepatocellular Carcinoma
Lihui Gu, Han Wu, Xu Li, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC
Cole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Radiotherapy and Oncology (2023) Vol. 190, pp. 110030-110030
Closed Access | Times Cited: 16
Recent Advances and Challenges in Stereotactic Body Radiotherapy
Atsuto Katano, Masanari Minamitani, Shingo Ohira, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 6
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
Ze-Rui Zhao, Shiliang Liu, Ting Zhou, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 12, pp. 988-996
Closed Access | Times Cited: 6
Translational Frontiers and Clinical Opportunities of Immunologically Fitted Radiotherapy
Daphné Morel, Charlotte Robert, Nikos Paragios, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 11, pp. 2317-2332
Open Access | Times Cited: 5
Comparing the Robustness of Intensity-Modulated Proton Therapy and Proton-Arc Therapy Against Interplay effects of 4D Robust-Optimized Plans for Lung Stereotactic Body Radiotherapy
Wei Wen, Hang Yu, Qingqing Xiao, et al.
Clinical Oncology (2025) Vol. 39, pp. 103757-103757
Closed Access
Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study
Zhou Meng-Xi, Wen-Jie Fan, Ning Zhang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Is it time to retire preoperative radiation for localized esophageal and gastro-esophageal adenocarcinoma?
Cindy M. Pabon, Benjamin Spieler, Jing Li, et al.
The Oncologist (2025) Vol. 30, Iss. 1
Open Access
Photon mini‐GRID therapy for preoperative breast cancer tumor treatment: A treatment plan study
Angela Corvino, Tim Schneider, Jeremi Vu‐Bezin, et al.
Medical Physics (2025)
Open Access
Impact of radiation dose to immune cells on survival in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a retrospective analysis
Junfeng Zhao, Kang Wang, Ying Li, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Low-Burden Oligometastatic Disease of the Lung Treated with Robotic Stereotactic Ablative Radiotherapy: A Retrospective Study
Anna Zygogianni, Ioannis M. Koukourakis, Zoi Liakouli, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 517-517
Open Access
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation
Zachary S. Morris, Sandra Demaria, Arta M. Monjazeb, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 3, pp. e152-e170
Closed Access
Hochpräzisionsstrahlentherapie bei Patient*innen mit NSCLC
Mahalia Zoe Anczykowski, Stefan Rieken, Martin Leu
TumorDiagnostik & Therapie (2025) Vol. 46, Iss. 02, pp. 109-112
Closed Access
Page 1 - Next Page

Scroll to top